Pharmacologic Alterations in Human Type I Atrial Flutter Cycle Length and Monophasic Action Potential Duration: Evidence of a Fully Excitable Gap in the Reentrant Circuit

Journal of the American College of Cardiology

Volumn 27, Issue 2, 1996, Pages 453-461

  Stambler, Bruce S ^a,c   Wood, Mark A ^a,b   Ellenbogen, Kenneth A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; EDROPHONIUM; ISOPRENALINE; PROCAINAMIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ATRIUM FLUTTER; HEART CONDUCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REENTRY TACHYCARDIA;

ACTION POTENTIALS; ADENOSINE; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; EDROPHONIUM; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; ISOPROTERENOL; MALE; PROCAINAMIDE;

EID: 0030021157     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00459-9     Document Type: Article

References (40)

1. Olshansky B, Wilber DJ, Hariman RA. Atrial flutter - update on the mechanism and treatment. Pace 1992;15:2308-36.
2. Disertori M, Inama G, Vergara G, Guarnerio M, Del Favero A, Furlanello F. Evidence of a reentry circuit in the common type of atrial flutter in man. Circulation 1983;67:434-40.
3. Inoue H, Matsuo H, Takayanagi K, Murao S. Clinical and experimental studies of the effects of atrial extrastimulation and rapid pacing on atrial flutter cycle. Evidence of macro-reentry with an excitable gap. Am J Cardiol 1981;48:623-31.
4. Arenal A, Almendral J, Roman DS, Delcan JL, Josephson ME. Frequency and implications for resetting and entrainment with right atrial stimulation in atrial flutter. Am J Cardiol 1992;70:1292-8.
5. Klein GJ, Guiraudon GM, Sharma AD, Milstein S. Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol 1986;57:587-91.
6. Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in human atrial flutter. J Am Coll Cardiol 1990;16:1639-48.
7. Boineau JP. Atrial flutter: a synthesis of concepts. Circulation 1985;72:249-57.
8. Wells JL, MacLean WAH, James TN, Waldo AL. Characterization of atrial flutter: studies in man after open heart surgery using fixed atrial electrodes. Circulation 1979;60:665-73.
9. Boyden PA. Effects of pharmacologic agents on induced atrial flutter in dogs with right atrial enlargement. J Cardiovasc Pharmacol 1986;8:170-7.
10. Frame LH, Page RL, Hoffman BF. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter. Circ Res 1986;58:495-511.
11. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977;41:9-18.
12. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine. Circulation 1991;83:1499-509.
13. Bellardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983;244:H734-7.
14. Clemo HF, Belardinelli L. Effect of adenosine on atrioventricular conduction: Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res 1986;59:427-36.
15. Dimarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, Belardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachycardia. J Am Coll Cardiol 1985;6:417-25.
16. Engelstein ED, Lippman N, Stein KM, Lerman BB. Mechanism specific effects of adenosine on atrial tachycardia. Circulation 1994;89:2645-54.
17. Lindemann JP, Watanabe AM. Sympathetic control of cardiac electrical activity. In: Zipes D, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Saunders, 1990:277-83.
18. Boyett MR, Jewell BR. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophys Mol Biol 1980;36:1-52.
19. Wit AL, Hoffman BF, Rosen MR. Electrophysiology and pharmacology of cardiac arrhythmias: IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A. Am Heart J 1975;90:521-33.
20. De Mello WC. Modulation of junctional permeability. Fed Proc 1984;43: 2692-6.
21. Waxman MB, Kirsh JA, Yao L, Cameron DA, Asta JA. Slowing of the atrial flutter rate during 1:1 atrioventricular conduction in humans and dogs: An effect mediated through atrial pressure and volume. J Cardiovasc Electrophysiol 1992;3:544-57.
22. Hoffman BF, Suckling EE. Cardiac cellular potentials: Effect of vagal stimulation and acetylcholine. Am J Physiol 1953;173:312-20.
23. Prystowsky EN, Naccarellli GV, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 1983;51:96-100.
24. Singh BN, Courtney KR. The classification of antiarrhythmic mechanisms of drug action: experimental and clinical considerations. In Ref. 17:882-97.
25. Campbell TJ. Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res 1983;17:344-52.
26. Kadish AH, Spear JF, Levine JH, Moore EN. The effects of procainamide on conduction in anisotropic canine ventricular myocardium. Circulation 1986; 74:616-25.
27. Feld GK, Venkatesh N, Singh BN. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. Circulation 1986;74:197-204.
28. Spinelli W, Hoffman BF. Mechanisms of termination of reentrant atrial arrhythmias by class I and III antiarrhythmic agents. Circ Res 1989;65:1565-79.
29. Wu KM, Hoffman BF. Effect of procainamide and N-acetylprocainamide on atrial flutter: Studies in vivo and in vitro. Circulation 1987;76:1397-408.
30. Schoels W, Yang H, Gough WB, El-Sherif N. Circus movement atrial flutter in the canine sterile pericarditis model: Differential effects of procainamide on the components of the reentrant pathway. Circ Res 1991;68:1117-26,
31. Kus T, Derakhchan K, Bouchard C, Page P. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia. PACE 1991;14:1707-13.
32. Markel LM, Miles WM, Luck JC, Klein LS, Prystowsky EN. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy. Circulation 1993;87:778-92.
33. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1971;29:437-45.
34. Allessie MA, Lammers WJEP, Bonke FIM, Hollen J. Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation 1984;70:123-35.
35. Niwano S, Ortiz J, Abe H, Gonzalez X, Rudy Y, Waldo AL. Characterization of excitable gap in a functionally determined reentry circuit. Studies in the sterile pericarditis model of atrial flutter. Circulation 1994;90:1997-2014.
36. Feld GK, Shahandeh-Rad F. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury. J Am Coll Cardiol 1992;20:441-51.
37. Waxman MB, Yao L, Cameron DA, Kirsh JA. Effects of posture, Valsalva maneuver and respiration on atrial flutter rate: an effect mediated through cardiac volume. J Am Coll Cardiol 1991;17:1545-52.
38. Josephson ME. Atrial flutter and fibrillation. In: Clinical Cardiac Electrophysiology. Philadelphia: Lea & Febiger, 1993:275-310.
39. Lammers WJ, Ravelli F, Disertori M, Antolini R, Furlanello F, Allessie MA. Variation in human atrial flutter cycle length induced by ventricular beats: evidence of a reentrant circuit with a partially excitable gap. J Cardiovasc Electrophysiol 1991;2:375-87.
40. Ravelli F, Disertori M, Cozzi F, Antolini R, Allessie MA. Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in humans. Evidence of leading circle reentry. Circulation 1994;89:2107-16.